Improving cognition in schizophrenia with antipsychotics that elicit neurogenesis through 5-HT(1A) receptor activation.
about
Lurasidone for the treatment of bipolar depression: an evidence-based reviewMonoaminergic and Histaminergic Strategies and Treatments in Brain DiseasesThe role of dopamine in schizophrenia from a neurobiological and evolutionary perspective: old fashioned, but still in vogue.The effect of second-generation antipsychotics on hippocampal volume in first episode of psychosis: longitudinal study.Influence of 5-HT1A and 5-HTTLPR genetic variants on the schizophrenia symptoms and occurrence of treatment-resistant schizophreniaCould vagus nerve stimulation target hippocampal hyperactivity to improve cognition in schizophrenia?Divergent effects of the 'biased' 5-HT1 A receptor agonists F15599 and F13714 in a novel object pattern separation task.Polymorphisms of serotonin neurotransmission and their effects on antipsychotic drug action.Editorial. New Targets of Medical Treatment in Psychiatric Disorders.Neurodevelopmental Perspectives on Wnt Signaling in Psychiatry.Antipsychotic inductors of brain hypothermia and torpor-like states: perspectives of application.From Gene to Behavior: L-Type Calcium Channel Mechanisms Underlying Neuropsychiatric Symptoms.The Neuropsychiatric Disease-Associated Gene cacna1c Mediates Survival of Young Hippocampal Neurons5-Hydroxytryptamine1A receptor-activation hyperpolarizes pyramidal cells and suppresses hippocampal gamma oscillations via Kir3 channel activation.Impaired glucose tolerance in first-episode drug-naïve patients with schizophrenia: relationships with clinical phenotypes and cognitive deficits.POU3F2 participates in cognitive function and adult hippocampal neurogenesis via mammalian-characteristic amino acid repeats.Comparative analysis of pharmacological properties of xanomeline and N-desmethylclozapine in rat brain membranes.Association Between Serotonin Syndrome and Second-Generation Antipsychotics via Pharmacological Target-Adverse Event Analysis.
P2860
Q26796437-4F9657A8-AA8A-4CAE-84B8-C0608BC8FE34Q28066691-14CBB556-E250-46C6-899B-3CD3A585A57AQ30437188-1BDA3DFB-5437-4DA7-98DC-2BB5AAD995F7Q30490077-2E68C969-8CF2-4668-935B-F04983FC8153Q35136003-598B0F7A-639C-4386-A6CE-BEEA84A2D672Q35211484-F2515BFA-849D-4068-AEF8-0A451C8A89F9Q35538516-4FBE1887-9B54-414B-8084-278316610017Q38262202-769411CF-AACD-4A57-A53B-6A1CBB33C5D2Q38553202-29F2D624-5A56-4DDA-9A9C-82DB1D0E9E70Q38917986-6B6B7468-CDE7-43F2-B716-FFB6F7A95ECCQ39033778-FE9A05AC-04A1-4D2E-9609-375434C0E5FDQ39301735-CC44612A-E0D4-48D1-848F-B24A1DB9B7A0Q39829373-71F324C5-FC41-4103-9ADA-498CE2E415C1Q46854592-20635F17-4B99-4C9B-A44F-DCE093DA9745Q47891942-68C7079C-81D1-4636-95D5-69D95D4C0B01Q48164256-C2648FA6-38D4-408F-8166-6B3C815325CEQ48600420-82EEAF81-0AF6-4957-9695-51721796147EQ55308829-D684C0D9-9006-4C6E-BDE7-C2A36FCF0814
P2860
Improving cognition in schizophrenia with antipsychotics that elicit neurogenesis through 5-HT(1A) receptor activation.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Improving cognition in schizop ...... 5-HT(1A) receptor activation.
@en
type
label
Improving cognition in schizop ...... 5-HT(1A) receptor activation.
@en
prefLabel
Improving cognition in schizop ...... 5-HT(1A) receptor activation.
@en
P1476
Improving cognition in schizop ...... 5-HT(1A) receptor activation.
@en
P2093
Rudy Schreiber
P356
10.1016/J.NLM.2013.12.015
P577
2014-01-11T00:00:00Z